SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]
SWHR submitted comments in response to the U.S. Department of Health and Human Services (HHS) Strategic Plan for Fiscal Years 2022-2026.
SWHR convened a diverse and interdisciplinary working group of clinical and public health researchers, health care providers, patients/patient advocates, and policy leaders for a closed, one-day roundtable meeting in December 2021, to discuss the health, social, and economic impacts of eye diseases that disproportionately affect women’s health.
The Society for Women’s Health Research (SWHR) published a paper in Biology of Sex Differences, capturing insights and recommendations from […]
Senate Appropriations Committee Chairman Patrick Leahy (D-VT) released the draft text of the nine remaining fiscal year (FY) 2022 appropriations bills, including the Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) spending bill with jurisdiction over the National Institutes of Health (NIH).
On October 26, 2021, SWHR hosted the congressional briefing, “Menopause Mindfulness: Exploring Menopause's Effect on Health and Well-Being,” where panelists shared information about menopause, including the health risks for women during this life stage and the stigma often associated with menopause and aging.
SWHR issued the following statement in response to the announcement that Francis S. Collins, MD, PhD, will step down as the director of the National Institutes of Health by the end of the year.
At the September Policy Advisory Council meeting, leadership from the Food and Drug Administration (FDA) and NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) discussed how they are working to advance the nation’s health with an emphasis on women’s health.
Maternal mortality rates in the United States continue to grow, with widening disparities in outcomes for Black, Indigenous, People of […]